| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |